Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) CFO Jeffrey L. Wade Acquires 12,000 Shares

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) CFO Jeffrey L. Wade bought 12,000 shares of the company’s stock in a transaction on Tuesday, June 20th. The stock was purchased at an average cost of $2.33 per share, for a total transaction of $27,960.00. Following the completion of the transaction, the chief financial officer now owns […]

Related Keywords

Jeffreyl Wade , ,Jpmorgan Chase Co ,Lexicon Pharmaceuticals Inc ,Geode Capital Management ,Institutional Trading Of Lexicon Pharmaceuticals ,News Ratings For Lexicon Pharmaceuticals Daily ,Jefferies Financial Group ,Lexicon Pharmaceuticals Stock Performance ,Lexicon Pharmaceuticals ,Lexicon Pharmaceuticals Company Profile ,Nasdaq ,Citigroup ,Schonfeld Strategic Advisors ,Get Rating ,Street Group ,Street Corp ,Capital Management ,Strategic Advisors ,Financial Group ,Lexicon Pharmaceuticals Daily ,Nasdaq Lxrx ,Lxrx ,Medical ,52887210 ,Insider Trading ,Nsider Trades ,Stocks ,